Universal Health Realty Income Trust (UHT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Universal Health Realty Income Trust.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 15 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 43.40 $ — 77% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 3.1% failed
- More than 10% revenue growth is expected for the coming year 5.3% failed
- Share count grows by less than 3% a year 0.2% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 40.8% passed
- Gross margin at 40% or higher and without meaningful erosion 94.4% passed
- Goodwill from acquisitions does not grow faster than revenue 0.0% passed
- Net debt below twice EBITDA 5.6 x EBITDA failed
- Operating cash flow covers the profits of the last three years 87 m passed
- Return on capital at 15% or higher, or up versus two years ago 6.2% failed
- Insiders hold at least 10% or are net buyers 8.4% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 1.4% above the current price.
- Consensus
- Strong Sell
- Analyst Ratings
- 1
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | – | – | 100 | – | 1 |
| 12/31/2027 | – | – | 105 | – | 1 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.34 | 29.50 | 25 | 1.30 | 18.90 | 13 | 13 |
| 2025: Q1 | 0.34 | -10.00 | 25 | -2.40 | 19.50 | 12 | 12 |
| 2025: Q2 | 0.32 | -15.00 | 25 | 0.50 | 18.10 | 14 | 14 |
| 2025: Q3 | 0.29 | 0.40 | 25 | 3.30 | 15.90 | 10 | 10 |
| 2025: Q4 | 0.31 | -7.30 | 74 | 200.20 | 5.80 | 14 | 14 |
| 2026: Q1 | 0.36 | 4.90 | 25 | -0.10 | 20.50 | 12 | 12 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 67 | 22 | 17 | 1.28 | 41 | 191 | 525 |
| 2017 | 72 | 24 | 46 | 3.35 | 46 | 211 | 490 |
| 2018 | 76 | 27 | 24 | 1.76 | 43 | 199 | 484 |
| 2019 | 77 | 26 | 19 | 1.38 | 43 | 182 | 489 |
| 2020 | 78 | 26 | 19 | 1.41 | 44 | 159 | 494 |
| 2021 | 84 | 29 | 109 | 7.92 | 48 | 235 | 598 |
| 2022 | 91 | 31 | 21 | 1.53 | 47 | 229 | 608 |
| 2023 | 96 | 31 | 15 | 1.11 | 43 | 201 | 596 |
| 2024 | 99 | 37 | 19 | 1.39 | 47 | 180 | 581 |
| 2025 | 99 | 35 | 18 | 1.27 | 49 | 152 | 565 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Universal Health Realty Income Trust, ein Real Estate Investment Trust, investiert in Gesundheits- und Sozialdiensteinrichtungen, darunter Akutkrankenhäuser, Einrichtungen für Verhaltensgesundheit, Rehabilitationskliniken, Subakutpflegeeinrichtungen, Operationszentren, Kinderbetreuungseinrichtungen und medizinische O…
| CEO Insider Trades (12 Mo.) | buying own stock |
|---|---|
| Headquarters | King of Prussia, PA |
| Address | Universal Corporate Center, 19406-0958 King of Prussia, United States |
| Phone | 610 265 0688 |
| Website | uhrit.com |
| IPO Date | 5. Nov 1987 |
| ISIN | US91359E1055 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Alan B. Miller | Chairman, President & CEO | 1938 |
| Charles F. Boyle | Senior VP & CFO | 1960 |
| Cheryl K. Ramagano | Senior VP of Operations, Treasurer & Secretary | 1963 |
| Robert F. McCadden CPA | Lead Independent Trustee | 1958 |
| Karla J. Peterson | Vice President of Acquisitions & Development | 1960 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.